- Home
- HSCS vs LIPO Comparison
HSCS vs LIPO Comparison
Compare HSCS & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- LIPO
- Stock Information
- Founded
- HSCS 2007
- LIPO 2005
- Country
- HSCS United States
- LIPO United States
- Employees
- HSCS N/A
- LIPO N/A
- Industry
- HSCS Medical Specialities
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- LIPO Health Care
- Exchange
- HSCS Nasdaq
- LIPO Nasdaq
- Market Cap
- HSCS 3.5M
- LIPO 3.1M
- IPO Year
- HSCS 2022
- LIPO 2022
- Fundamental
- Price
- HSCS $3.43
- LIPO $2.40
- Analyst Decision
- HSCS Strong Buy
- LIPO
- Analyst Count
- HSCS 2
- LIPO 0
- Target Price
- HSCS $13.00
- LIPO N/A
- AVG Volume (30 Days)
- HSCS 13.9K
- LIPO 156.6K
- Earning Date
- HSCS 03-13-2025
- LIPO 05-20-2025
- Dividend Yield
- HSCS N/A
- LIPO N/A
- EPS Growth
- HSCS N/A
- LIPO N/A
- EPS
- HSCS N/A
- LIPO N/A
- Revenue
- HSCS N/A
- LIPO $536,357.00
- Revenue This Year
- HSCS N/A
- LIPO N/A
- Revenue Next Year
- HSCS N/A
- LIPO N/A
- P/E Ratio
- HSCS N/A
- LIPO N/A
- Revenue Growth
- HSCS 261.17
- LIPO 19.29
- 52 Week Low
- HSCS $2.36
- LIPO $1.97
- 52 Week High
- HSCS $13.50
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- HSCS 54.77
- LIPO 45.04
- Support Level
- HSCS $3.38
- LIPO $2.40
- Resistance Level
- HSCS $3.62
- LIPO $2.56
- Average True Range (ATR)
- HSCS 0.23
- LIPO 0.16
- MACD
- HSCS 0.00
- LIPO -0.00
- Stochastic Oscillator
- HSCS 39.46
- LIPO 52.13
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.